ORKA – oruka therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Oruka Therapeutics (NASDAQ:ORKA) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock, up previously from $42.00.
Oruka Therapeutics (NASDAQ:ORKA) had its price target raised by analysts at BTIG Research from $63.00 to $73.00. They now have a "buy" rating on the stock.
Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001 [Yahoo! Finance]
Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001
Oruka Therapeutics (NASDAQ:ORKA) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Form 4 Oruka Therapeutics, Inc. For: Jan 02 Filed by: Sandler Laura Lee
Form 144 Oruka Therapeutics, Inc. Filed by: Sandler Laura Lee
Form 4 Oruka Therapeutics, Inc. For: Dec 19 Filed by: Goncalves Joana
Form 144 Oruka Therapeutics, Inc. Filed by: Goncalves Joana
Form 4 Oruka Therapeutics, Inc. For: Dec 11 Filed by: Martin Christopher Nathan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.